As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
Prof. Nicolas Barry-Delongchamps, Professor of Urology at Cochin Hospital and Principal Investigator of the VIOLETTE trial, will present the final results and one-year patients follow-up from the ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
The technology is available on the new MyLabE85 GTS Edition that will be showcased together with the brand new MyLabC30 GTS ...
URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided system that combines magnetic resonance imaging (MRI) with precise prostate ...
At ECR 2026, UII reaffirmed its AI development principles, which are anchored in clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiology knowledge into a ...
Esaote presents its new and innovative technology dedicated to urology: the exclusive Prostate Attention Map (PAM), now ...
In 2025, adults aged 25-34 FAIR Health Consumer, while adults 65 and older (the largest user group in 2024) remained a high proportion of users. FAIR Health Consumer (fairhealthconsumer.org) is FAIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results